Skip to main content
BAK
NYSE Industrial Applications And Services

Braskem 2Q26: EBITDA Soars to $1B, But Default and D-Rating Loom

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
9
Price
$2.35
Mkt Cap
$726.041M
52W Low
$2.03
52W High
$5.395
52W Position info
16% above low
Off High info
56% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

BAK sits 16% above its 52-week low of $2.03.

Summary

Braskem reported 2Q26 Recurring EBITDA of US$1.0 billion, a massive improvement from 1Q26, but disclosed it is in default on certain debt and its credit rating was cut to D by S&P.


Key Events · Earnings and Guidance · BAK

  • EBITDA Surges to $1B

    2Q26 Recurring EBITDA reached US$1.0 billion, up from US$192 million in 1Q26, driven by higher international spreads for resins and chemicals due to the Middle East conflict.

  • Net Income Turns Positive

    Net income attributable to shareholders was US$664 million in 2Q26, compared to a loss in 1Q26, reflecting the EBITDA improvement.

  • Default and Downgrade

    The company is in default under certain financial instruments as of July 2026, and S&P downgraded its global credit rating to D on June 26, 2026.

  • Debt Restructuring Continues

    Braskem remains in mediation with creditors, with no agreement reached. Its Mexican subsidiary Braskem Idesa is considering Chapter 11 under U.S. law.


Analysis · BAK · Industrial Applications And Services

Braskem's 2Q26 results show a dramatic EBITDA surge to US$1.0 billion from US$192 million in 1Q26, driven by Middle East conflict-driven spreads. However, the company is now in default on certain financial obligations, has been downgraded to D by S&P, and its Mexican subsidiary is considering Chapter 11. The earnings beat is overshadowed by the deepening restructuring crisis.

At the time of this filing, BAK was trading at $2.35 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $726M. The 52-week trading range was $2.03 to $5.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BAK - Latest Insights

BAK
Aug 14, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.20
Real-time Price: $2.34 info
Change: +$0.140 (+6%) info
Market Cap: $726.041M info
BAK
Jul 31, 2026, 7:29 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.36
Real-time Price: $2.34 info
Change: -$0.020 (-0.85%) info
Market Cap: $726.041M info
BAK
Jul 30, 2026, 8:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.39
Real-time Price: $2.34 info
Change: -$0.050 (-2%) info
Market Cap: $726.041M info
BAK
Jul 28, 2026, 8:37 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.33
Real-time Price: $2.34 info
Change: +$0.011 (+0.47%) info
Market Cap: $726.041M info
BAK
Jul 21, 2026, 8:49 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.31
Real-time Price: $2.34 info
Change: +$0.030 (+1%) info
Market Cap: $726.041M info